Results 121 to 130 of about 1,867,213 (332)

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

open access: yesMolecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici   +8 more
wiley   +1 more source

[Multivariate repeated measures designs].

open access: yesPsicothema, 2007
In the social, behavioral, and health researches it is a common strategy to collect data along time on more than one group of participants on multiple dependent variables. To analyse this kind of data is very complicated due to the correlations between the measures taken in different points of the time, and between the answers. Usually to analyse these
Guillermo, Vallejo, Luis M, Lozano
openaire   +1 more source

Stages of Change in the Trajectory of Postpartum Weight Self-Management [PDF]

open access: yes, 2012
Objective To identify women\u27s patterns of readiness to engage in weight self-management behaviors during the postpartum period. Design Prospective, longitudinal design with repeated measures, guided by the transtheoretical model of behavior change ...
Ohlendorf, Jennifer M.
core   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Combinatorial problems in repeated measurements designs

open access: yesDiscrete Mathematics, 1989
In the recent past a number of papers on design of experiments have considered the structure of designs with certain desirable properties. In a repeated measurements designs (RMD) there are t treatments, n experimental units and the experiment lasts for p periods. Each experimental unit receives one treatment during each period.
openaire   +2 more sources

Increased Lower Limb Spasticity but Not Strength or Function Following a Single-Dose Serotonin Reuptake Inhibitor in Chronic Stroke [PDF]

open access: yes, 2015
Objective: To investigate the effects of single doses of a selective serotonin reuptake inhibitor (SSRI) on lower limb voluntary and reflex function in individuals with chronic stroke. Design: Double-blind, randomized, placebo-controlled crossover trial.
Gourab, Krishnaj   +2 more
core   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

Effect of Psychostimulant Medications on Muscle Tone in Adults with Attention Deficit Hyperactivity Disorder: Within-Subject Repeated-Measure Study Design  [PDF]

open access: green, 2022
Mansour M. Alotaibi   +5 more
openalex   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy